|
Apr 12
|
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
|
|
Apr 11
|
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?
|
|
Apr 10
|
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
|
|
Apr 8
|
Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
|
|
Apr 4
|
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
|
|
Apr 3
|
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
|
|
Apr 1
|
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
|
|
Mar 22
|
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
|
|
Mar 4
|
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR
|
|
Feb 14
|
Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Feb 14
|
The Zacks Analyst Blog Highlights Globus Medical, Glaukos, PROCEPT, Edwards Lifesciences and Quest Diagnostics
|
|
Feb 13
|
What's in Store for West Pharmaceutical (WST) in Q4 Earnings?
|
|
Feb 13
|
3 Medtech Stocks Likely to Top Estimates This Earnings Season
|
|
Jan 11
|
Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand
|
|
Jan 9
|
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
|
|
Dec 23
|
Glaukos Corp President & COO Joseph Gilliam Sells 25,000 Shares
|
|
Dec 20
|
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
|
|
Dec 19
|
Glaukos' (GKOS) iDose TR Gets FDA Nod for Glaucoma Treatment
|
|
Dec 18
|
Glaukos (GKOS) Hits 52-Week High: What's Aiding the Stock?
|
|
Dec 3
|
Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week
|